(Q80998329)

English

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients

scientific article published on 01 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Ali Fattom

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steve Fuller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Myra Propst

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Scott Winston

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Larry Muenz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

David He

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Robert Naso

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gary Horwith

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

656-663

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Methicillin-resistant Staphylococcus aureus in the community: a hospital-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

The economic impact of Staphylococcus aureus infection in New York City hospitals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Use of licensed vaccines for active immunization of the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Speculations on the immunology of staphylococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Polysaccharide-protein conjugates: a new generation of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.06.043

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15542186%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80998329&oldid=2164899270"